VYNE Therapeutics to Participate in Leerink Partners Therapeutics Forum

June 26, 2024

https://www.globenewswire.com/news-release/2024/06/26/2904448/0/en/VYNE-Therapeutics-to-Participate-in-Leerink-Partners-Therapeutics-Forum.html

BRIDGEWATER, N.J., June 26, 2024 (GLOBE NEWSWIRE) — VYNE Therapeutics Inc. (Nasdaq:VYNE) (“VYNE” or the “Company”), a clinical-stage biopharmaceutical company developing proprietary, innovative, and differentiated therapies for the treatment of immuno-inflammatory conditions, today announced members of VYNE’s management will participate in one-on-one meetings at the Leerink Partners Therapeutics Forum on Immunology and Inflammation (I&I) and Metabolic Diseases on Tuesday, July 9, 2024.

Read more at globenewswire.com

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.